Avinger, Inc.

NASDAQ
AVGR
Terfi
Altı ay boyunca karlılık: +20.8%
Temettü getirisi: 0%
Sektör: Healthcare

0.474 $

0 $ 0%
0.3911 $
1.45 $

Min./max. bir yıl boyunca

Promosyon programı Avinger, Inc.

Ana parametreler

Halka arz süresi
2015-01-30
ISIN
US0537348858
Para birimi
usd
Raporun para birimi
usd
Sanayi
Health Care Equipment & Supplies
Sektör
Health Care
Web sitesi

Seviye

Hafife alma
İsim Anlam Seviye
P/S 0.2825 10
P/BV -0.3485 0
P/E 0 0
Yeterlik
İsim Anlam Seviye
ROA -133.04 0
ROE 295.39 10
ROIC 0 0
Temettü
İsim Anlam Seviye
Temettü getirisi 0 0
DSI 0 0
Temettülerin ortalama büyümesi 0 0
Görev
İsim Anlam Seviye
Debt/EBITDA -1.01 10
Debt/Ratio 1.12 8
Debt/Equity -3.22 10
Büyüme darbesi
İsim Anlam Seviye
Gelir, milyar, % -15.91 0
Ebitda, % -15.74 0
EPS, % -57.29 0

Fiyat

Fiyat Min. Maksimum. Değiştirmek Sektördeki değişiklikler Dizindeki değişiklikler
Dün 0.474 $ 0 $ 0 $ 0 % 0 % 0 %
Hafta 0.474 $ 0 $ 0 $ 0 % 0 % 0 %
Ay 0.474 $ 0 $ 0 $ 0 % 0 % 0 %
3 ay 0.474 $ 0.474 $ 0.474 $ 0 % 0 % 0 %
Altı ay 0.3924 $ 0.474 $ 0.598 $ +20.8 % 0 % 0 %
Yıl 1.1 $ 0.3911 $ 1.45 $ -56.91 % 0 % 0 %
3 yıl 1.47 $ 0.3911 $ 22.95 $ -67.76 % 0 % 0 %
5 yıl 0.5578 $ 0.18 $ 22.95 $ -15.02 % 0 % 0 %
10 yıl 0.178 $ 0.178 $ 24.75 $ +266.29 % 0 % 0 %
Sene başından beri 0.609 $ 0.3911 $ 0.828 $ -22.17 % 0 % 0 %

Temel Sahipler

Benzer Şirketler



Şirketin yönetimi

Amir İş unvanı Ödeme Doğum yılı
Mr. Jeffrey M. Soinski CEO & Director 616.79k 1962 (63 yıl)
Mr. Nabeel P. Subainati Vice President of Finance 347.58k 1984 (41 yıl)
Mr. Himanshu N. Patel Chief Technology Officer 430.08k 1960 (65 yıl)
Mr. Keith Schaefer Chief Operating Officer N/A
Mr. Corey Gibbs Vice President of Sales N/A
Dr. Jaafer Golzar FACC, M.D. Chief Medical Officer N/A
Mr. Philip R. Preuss Chief Marketing Officer & VP of Business Operations N/A 1978 (47 yıl)

Şirket hakkında bilgi

Adres: United States, Redwood City. CA, 400 Chesapeake Drive - Google kartlarında açın, Açık yandex kartları
Web sitesi: https://avinger.com

Şirket hakkında Avinger, Inc.

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.